The Incidence Of Bladder Cancer after Cyclophosphamide Therapy
- 1 August 1979
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 122 (2) , 163-164
- https://doi.org/10.1016/s0022-5347(17)56306-5
Abstract
The records of 19,082 patients with non-uroepithelial cancers were reviewed to determine the incidence of de novo bladder cancer in patients treated with cyclophosphamide vs. patients not treated with this drug. A 9-fold increased incidence of bladder cancer was found in the cyclophosphamide-treated group.This publication has 14 references indexed in Scilit:
- Carcinoma of the Urinary Bladder in Patients Receiving CyclophosphamideNew England Journal of Medicine, 1975
- CyclophosphamideJournal of Urology, 1975
- Transitional Cell Carcinoma of the Bladder Associated with CyclophosphamideJournal of Urology, 1974
- Urological Complications of CyclophosphamideBritish Journal of Urology, 1973
- Cytotoxic Drugs in Treatment of Nonmalignant DiseasesAnnals of Internal Medicine, 1972
- Cyclophosphamide and the bladder.BMJ, 1971
- Urinary-Bladder Fibrosis and Telangiectasia Associated with Long-Term Cyclophosphamide TherapyNew England Journal of Medicine, 1971
- Hemorrhagic Cystitis Due to CyclophosphamideJournal of Urology, 1969
- Cyclophosphamide TherapyArchives of internal medicine (1960), 1961
- Neuartige Krebs-Chemotherapeutika aus der Gruppe der zyklischen N-Lost-PhosphamidesterThe Science of Nature, 1958